ESG

As WD-40 leaders prepare for the ICR Conference, investors weigh strong growth plans against a recent earnings miss and a major brand overhaul.

The University of Tulsa celebrates a historic achievement as 11 students secure prestigious Gilman scholarships, unlocking transformative study abroad experiences.

MES Life Safety has offloaded its alleged PFAS liabilities to a third party, a strategic move to de-risk its finances and focus on its core mission.

Economist Jim Rickards says the U.S. is on the verge of a mineral boom, but a complex web of new rules and legal fights complicates the path forward.

At CES 2026, Chinese robotics firm RoboCT unveiled a bold strategy to turn exoskeletons from medical aids into everyday 'new organs' for all.

A massive partnership aims to build gigawatt-scale data centers for OpenAI's 'Stargate' project, merging AI ambition with immense energy demands.

A Somerville clinic is tackling the crisis of fragmented specialty pet care by adding an in-house cardiologist, promising faster and more integrated treatment.

With drug costs soaring, industry veteran Ritu Malhotra joins Illuminate Rx, promising to disrupt the opaque PBM market. But can transparency truly win?

The brand's new non-toxic, fine-fragrance Scent Boosters aim to transform laundry from a chore into a luxurious ritual with lasting, high-tech scents.

Alto's ambitious high-speed rail plan is moving forward, with the Montréal-Ottawa line as its first phase. Public consultations are set to begin this month.

Biotech firm Bright Minds Biosciences closes a massive $175M deal, fueling its race to develop novel drugs for epilepsy and rare neurological conditions.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

As part of a $23B US investment, Novartis will build a cutting-edge facility in Winter Park, cementing Florida’s role in advanced cancer treatment.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

A new platform promises high daily returns for XRP investors by linking crypto to renewable energy, but a closer look reveals significant red flags.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

A Texas firm delivered 1.9M tons of carbon removals via ranching, paying farmers millions and showing how soil can be a powerful climate solution.

Amazon Pharmacy now offers the new Wegovy pill with transparent cash-pay options, shaking up the high-demand weight management drug market.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.